| Patient | Hippocrates |
|---|---|
| Date of birth | 1937-01-10 |
| Identifiers | MRN HR-AC005-SYN; SSN (made up) 000-05-8153 |
| Document date | 2026-06-29 |
| Author | Eleni Vasquez-Okafor, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four-month review. [S]
Hippocrates finished twelve weeks of physical therapy and goes to tai chi twice a week. He walks into town for his teaching and stops once on the hill. His knees ache at 2 of 10 on the hill; he uses the gel most mornings and acetaminophen two or three times a week. He has had no falls and no dizziness. He takes vitamin D3 daily. He had the RSV and first zoster vaccines three weeks ago with a sore arm for a day. [S]
| Element | Detail |
|---|---|
| Mobility | Gait speed 0.92 m/s; Timed Up and Go 11.4 seconds; 10 chair stands; tandem stance 10 seconds |
| Grip | 26 kg right, 24 kg left |
| Knee | Pain 2 of 10; KOOS JR 74 |
| Vitamin D | 33 ng/mL |
| Falls | None |
| System | Result | Finding |
|---|---|---|
| Musculoskeletal | Positive | Knee ache on the hill, 2 of 10 |
| Neurological | Negative | No dizziness |
| Constitutional | Negative | Energy good; weight steady |
3 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naproxen sodium 220 mg oral tablet, one or two tablets most days for knee pain, bought over the counter, for about two years; stopped at intake (Beers 2023: avoid chronic use) | One or two tablets by mouth up to twice a day, self-directed | Oral route | 2024-03-01 to 2026-03-02 | stopped | S |
| Diphenhydramine 25 mg oral capsule at bedtime three or four nights a week for sleep, bought over the counter; stopped at intake (Beers 2023: strongly anticholinergic) | One capsule at bedtime as needed, self-directed | Oral route | 2025-09-01 to 2026-03-02 | stopped | S |
| Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee pain, no more than 3,000 mg in a day | One to two tablets by mouth every eight hours as needed; no more than six tablets a day | Oral route | 2026-03-02 | active | S |
| Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily | One tablet by mouth daily | Oral route | 2026-03-02 | active | S |
| Diclofenac 1% gel, 4 g rubbed into each painful knee up to four times a day | Apply 4 g to each painful knee up to four times a day | Topical route | 2026-03-16 | active | S |
| Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestion | Two sprays in each nostril up to every four hours as needed | Nasal route | 2026-04-13 to 2026-04-23 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-29 | Body height | 168 | cm | S |
| 2026-06-29 | Body weight | 64.6 | kg | S |
| 2026-06-29 | Body mass index (BMI) [Ratio] | 22.9 | kg/m2 | S |
| 2026-06-29 | Systolic blood pressure | 132 | mm[Hg] | S |
| 2026-06-29 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-06-29 | Heart rate | 64 | /min | S |
| 2026-06-29 | Respiratory rate | 16 | /min | S |
| 2026-06-29 | Body temperature | 36.5 | Cel | S |
| 2026-06-29 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-29 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 33 | ng/mL | Below 20 ng/mL deficient; 20 to 29 insufficient | Normal | S |
| 2026-06-29 | Grip strength Hand - left Dynamometer | 24 | kg | S | ||
| 2026-06-29 | Grip strength Hand - right Dynamometer | 26 | kg | S | ||
| 2026-06-29 | Total interval score [KOOSJR] | 74 | {score} | S | ||
| 2026-06-29 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 | {score} | S |
Vital signs recorded on 2026-06-29; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 132/72 seated and 130/72 standing; pulse 64; weight 64.6 kg |
| Musculoskeletal | Both knees: crepitus, no effusion; quadriceps 5 of 5 on the right, 4+ of 5 on the left |
| Neurological | Rises from a chair without his arms; turns steadily |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Slower walking, knee pain on stairs and one near-fall in the past six months, found on the comprehensive geriatric assessment at intake: gait speed 0.78 m/s, Timed Up and Go 13.8 seconds, unable to hold a tandem stance for 10 seconds, grip 24 kg; cause under evaluation with a geriatric medicine consultation | resolved | confirmed | R26.81 | S — Synthetic presenting problem of normal aging found on a comprehensive geriatric assessment; superseded at the consultation, when knee osteoarthritis with reduced leg strength and balance was diagnosed. |
| Primary osteoarthritis of both knees, diagnosed clinically by the ACR criteria (knee pain, age over 50, morning stiffness under 30 minutes, crepitus, bony enlargement, no warmth), with reduced quadriceps strength and balance and an increased risk of falls; KOOS JR 62 | active | confirmed | M17.0 | S — Synthetic modern diagnosis made at the consultation: a common, mild condition of aging chosen for a figure with no documented illness; not a claim about his real knees. |
| Potentially inappropriate over-the-counter medicines (Beers 2023): naproxen most days for about two years and diphenhydramine for sleep three or four nights a week; both stopped at intake | resolved | confirmed | Z79.1 | S — Synthetic medication history found on the deprescribing review. |
| Low bone mass (femoral neck T-score -1.7, total hip -1.4) with vitamin D insufficiency (24 ng/mL); FRAX 10-year risk 11 percent major and 2.6 percent hip, below treatment thresholds | active | confirmed | M85.89 | S — Synthetic DXA finding at eight weeks; not a claim about his real bones. |
| Common cold (viral upper respiratory infection) with runny nose, sore throat and a mild cough, no fever, chest clear, oxygen saturation 97 percent; COVID-19 and influenza tests negative; resolved in about ten days | resolved | confirmed | J06.9 | S — Synthetic acute illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Knee pain (0 to 10) | Every visit | Completed today | 2 of 10 |
| Survey | Knee function (KOOS JR) | Every visit | Completed today | 74, from 62 at intake |
| Examination | Knee examination (range of movement, effusion, alignment, crepitus) | Every visit | Completed today | Crepitus, no effusion; quadriceps 5 and 4+ of 5 |
| Self-management | Exercise and self-management (strength and balance program, tai chi) | Every visit | Completed today | Twelve weeks of physical therapy finished; tai chi twice a week |
| Examination | Gait speed, Timed Up and Go, 30-second chair stand and four-stage balance test | At intake and after a strength and balance program | Completed today | Gait speed 0.92 m/s (from 0.78); Timed Up and Go 11.4 seconds (from 13.8); 10 chair stands (from 7); tandem stance 10 seconds (from 6) |
| Examination | Grip strength | At intake and after the program | Completed today | 26 kg right, 24 kg left (from 24 and 22) |
| Examination | Orthostatic blood pressure | At assessment and with any dizziness | Completed today | 132/72 seated, 130/72 standing |
| Medication safety | Medication review (Beers 2023): no NSAID tablets, sedating antihistamines or other anticholinergic medicines; over-the-counter purchases | Every visit | Completed today | No NSAID tablets, sleep aids or cold remedies |
| Medication safety | Topical diclofenac: skin and use | Every visit | Completed today | Most mornings; no skin irritation |
| Laboratory | 25-hydroxyvitamin D | At baseline, after repletion, then yearly | Completed today | 33 ng/mL after four months of vitamin D3, from 24 |
| Imaging | DXA and FRAX | At assessment, then every two years if untreated | Up to date | Done at eight weeks; repeat in two years |
| Survey | What matters most (4Ms) | Every visit | Completed today | Walking to his teaching, one stop on the hill |
| Survey | Mentation: mood, memory and sleep (4Ms) | Every visit | Completed today | Mini-Cog 5 and PHQ-2 0 at the wellness visit; sleeping well |
Goal progress:
Guideline basis: Age-Friendly Health Systems: the 4Ms (What Matters, Medication, Mentation, Mobility) (2026); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); Updating STEADI for Primary Care: Recommendations From the American Geriatrics Society Workgroup (2025); World guidelines for falls prevention and management for older adults: a global initiative (2022); Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management (2019); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); The clinician's guide to prevention and treatment of osteoporosis (2022); CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis, and osteoporosis monographs (2026)
Follow-up: Seven-month review in three months with the second zoster dose and the influenza vaccine. The clinic for any fall. Next scheduled visit 2026-09-28: seven-month review: knee function, mobility, falls, medicines, vaccines and what matters most to him. [S]